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Stroke represents the fifth most common cause of mortality within the United States, with approxi-mately one person dying of stroke every 3.6 min-
utes.1 There continues to be an emphasis on accurate and 
rapid detection, as time to treatment is paramount in opti-
mizing outcomes. The timing of intervention within acute 
ischemic stroke care is critical, with national guidelines 
calling for a door-to-treatment time of less than 1 hour.2,3 
Several factors may contribute toward delays in stroke 
diagnosis and treatment. Two established contributors 
are prolonged stroke imaging (> 20 minutes) and compli-
cated triage/transport by emergency medical services de-
laying imaging.4 Both of these factors stem in part from 
limitations of currently available diagnostic technologies, 
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OBJECTIVE Stroke is a leading cause of morbidity and mortality. Current diagnostic modalities include CT and MRI. 
Over the last decade, novel technologies to facilitate stroke diagnosis, with the hope of shortening time to treatment and 
reducing rates of morbidity and mortality, have been developed. The authors conducted a systematic review to identify 
studies reporting on next-generation point-of-care stroke diagnostic technologies described within the last decade.
METHODS A systematic review was performed according to PRISMA guidelines to identify studies reporting noninva-
sive stroke diagnostics. The QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies-2) tool was utilized to as-
sess risk of bias. PubMed, Web of Science, and Scopus databases were utilized. Primary outcomes assessed included 
accuracy and timing compared with standard imaging, potential risks or complications, potential limitations, cost of the 
technology, size/portability, and range/size of detection.
RESULTS Of the 2646 reviewed articles, 19 studies met the inclusion criteria and included the following modalities of 
noninvasive stoke detection: microwave technology (6 studies, 31.6%), electroencephalography (EEG; 4 studies, 21.1%), 
ultrasonography (3 studies, 15.8%), near-infrared spectroscopy (NIRS; 2 studies, 10.5%), portable MRI devices (2 stud-
ies, 10.5%), volumetric impedance phase-shift spectroscopy (VIPS; 1 study, 5.3%), and eddy current damping (1 study, 
5.3%). Notable medical devices that accurately predicted stroke in this review were EEG-based diagnosis, with a maxi-
mum sensitivity of 91.7% for predicting a stroke, microwave-based diagnosis, with an area under the receiver operating 
characteristic curve (AUC) of 0.88 for differentiating ischemic stroke and intracerebral hemorrhage (ICH), ultrasound with 
an AUC of 0.92, VIPS with an AUC of 0.93, and portable MRI with a diagnostic accuracy similar to that of traditional MRI. 
NIRS offers significant potential for more superficially located hemorrhage but is limited in detecting deep-seated ICH 
(2.5-cm scanning depth).
CONCLUSIONS As technology and computational resources have advanced, several novel point-of-care medical de-
vices show promise in facilitating rapid stroke diagnosis, with the potential for improving time to treatment and informing 
prehospital stroke triage.
https://thejns.org/doi/abs/10.3171/2021.4.FOCUS21122
KEYWORDS eddy current damping; near-infrared spectroscopy; volumetric impedance phase-shift spectroscopy; 
microwave; ischemic stroke; hemorrhagic stroke
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including the lack of portability of CT and MRI, which 
heavily depends on factors such as hospital crowding and 
geographic location.5,6
To address these shortcomings, several novel tech-
nologies and approaches have been developed to facili-
tate the diagnosis of stroke, with the hope of shortening 
the time to treatment and reducing the rates of morbidity 
and mortality. These approaches vary widely and include 
microwave-based analysis, volumetric impedance phase-
shift spectroscopy (VIPS), near-infrared spectroscopy 
(NIRS), electroencephalography (EEG), transcranial 
Doppler ultrasound, and eddy current damping (ECD), 
among others.7–14 Several of these technologies have al-
ready progressed to clinical trials, and some have gained 
clearance from the FDA.8,15 Despite major differences in 
operational principles, all of these newly emerging tech-
nologies share a similar end goal: to develop portable di-
agnostic technology in an effort to more efficiently triage 
stroke care.7–14
As stroke diagnostic technology continues to prog-
ress and novel technological avenues are discovered, it is 
imperative to assess the efficacy of these next-generation 
medical devices to ensure that the most efficient and ac-
curate diagnostic and treatment plans are utilized. In this 
study, we conducted a contemporary systematic review of 
the current state of point-of-care stroke detection.
Methods
Search Strategy
In February 2021, a search of the PubMed, Web of 
Science, and Scopus databases in accordance with the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines (Fig. 1) was con-
ducted. To identify studies reporting novel stroke diag-
nostic techniques, we used the following Boolean search 
terms: ((stroke OR hemorrhagic stroke OR thrombotic 
stroke OR ischemic stroke OR embolic stroke) AND ((di-
FIG. 1. PRISMA flowchart outlining the search and review process used to identify and select articles for inclusion in this system-
atic review.
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agnos* OR detection) AND (tool OR tech* OR device 
OR instrument OR machine)) AND (portable OR mobile 
OR compact OR point-of-care OR prehospital OR rapid)). 
The same search terms were used for each database, and 
syntax was adjusted accordingly. The reference lists of all 
included studies were also reviewed. Two authors (D.W. 
and S.M.J.H.) independently reviewed each article, and 
any discrepancies were discussed by an arbitrator (S.S.) 
until consensus was reached. D.W. and S.M.J.H. per-
formed data extraction once the list of included studies 
was finalized.
Selection Criteria and Data Collection
Overall, the initial search identified 2646 studies. Re-
moval of duplicates yielded 1895 studies, after which the 
following search criteria were applied: 1) studies describ-
ing stroke diagnostic technologies or devices other than 
traditional CT or MRI, 2) studies published within the last 
10 years, and 3) studies written in the English language. 
The full text was reviewed if any discrepancies arose 
while parsing through the studies. This process yielded 
a total of 92 studies. Studies were excluded if they 1) in-
volved conventional methods such as CT or MRI, 2) were 
book chapters, 3) were animal and/or nonhuman models, 
or 4) demonstrated biomarker detection of stroke (rather 
than medical device development). Nineteen studies met 
the inclusion and exclusion criteria and were included in 
the systematic review analysis. Outcomes were prespeci-
fied and included the cost of the technology, accuracy and 
timing compared with standard imaging, potential risks or 
complications, potential limitations, size/portability, and 
range/size of detection.
Risk of Bias Analysis
The Quality Assessment of Diagnostic Accuracy Stud-
ies–2 (QUADAS-2) tool was used to assess risk of bias 
(Table 1). This assessment tool is recommended by the 
Agency for Healthcare Research and Quality, the Cochrane 
Collaboration, and the United Kingdom National Institute 
for Health and Clinical Excellence. The QUADAS-2 itself 
encapsulates the following four metrics that may increase 
study bias: 1) patient selection, 2) evaluation of index tests, 
3) evaluation of reference standards, and 4) flow and tim-
ing.16–19 Based on several yes/no questions, each of these 
metrics is then ranked as high risk of bias, low risk of bias, 
or unclear. The risk of bias was assessed independently 
by S.S., D.W., and S.M.J.H. for this systematic review, and 
any discrepancies were discussed until a consensus was 
reached.
Results
Included Diagnostic Stroke Platforms
Of the 19 studies identified through our systematic 
review, 6 implemented microwave technology (31.6%), 
4 used EEG (21.1%), 3 used ultrasonography (15.8%), 2 
used NIRS (10.5%), 2 used portable MRI devices (10.5%), 
1 used VIPS (5.3%), and 1 used ECD (5.3%) (Fig. 2). A 
summary of each study, including the diagnostic tool 
used, accuracy, and advantages or limitations of the tool 
are included in Table 2.
Stroke Diagnosis Using Microwaves
Several methods of nonionizing stroke detection are un-
der investigation. The most popular medical device being 
TABLE 1. Summary of QUADAS-2 tool assessment for all reviewed studies
Authors  
& Year
Risk of Bias:  
Patient Selection
Risk of Bias: Evaluation 
of Index Test
Risk of Bias: Evaluation 
of Reference Standard
Risk of Bias:  
Flow & Timing
FDA, 201015 Unclear Low High Unclear
Abtahi et al., 20127 Unclear Low High Unclear
Schlachetzki et al., 201226 Low Low Low High
Persson et al., 201411 Unclear Low High Unclear
Michelson et al., 201523 Low High High Low
Mobashsher et al., 201614 Low High High Low
Brogan et al., 20179 Low Low Low High
Bashri et al., 201721 Low Low Low Low
Kellner et al., 20188 High Low Low High
Thorpe et al., 201927 High High High Unclear
Coli et al., 201922 Low High Low Low
Shreve et al., 201913 Low Low Low Low
Alqadami et al., 202020 Low Low Low High
Cooley et al., 202129 Low Low Low Unclear
Gottlibe et al., 202010 Low Low Low Low
Guasch et al., 202025 Low Low Low Low
Shahrestani et al., 202012 Low High Low Unclear
Sheth et al., 202128 Low Low Low High
Wilkinson et al., 202024 Low Low Low High
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investigated for stroke diagnosis involves microwave-based 
stroke sensing.7,11, 14, 20–22 This method was first described by 
Abtahi et al. in 2012.7 All of the studies investigating mi-
crowave technology underscored the low-cost, portability, 
and rapid diagnostic time of this method.7 In addition, this 
technology is good at distinguishing between ischemic and 
hemorrhagic stroke subtypes (Table 3).11 However, several 
limitations need to be addressed as they pertain to these 
sensors. First, the interface between the sensor and the head 
is an important consideration to maximize radiofrequency 
transmission through the skull. Abtahi et al. utilized a water 
bolus between the antenna and head to ensure signal trans-
duction and described signal attenuation and leakage into 
free space instead of transmission into the head when us-
ing this technique.7 Similarly, the current spatial and depth 
resolution of microwave imaging is subpar and requires 
improvement. Several studies have noted that, at their cur-
rent capacity, microwave-based technologies are unable to 
solely dictate thrombolytic therapy because small targets 
may not actually be detected.11,14 One method of address-
ing the problem of resolution is by multiplexing microwave 
sensors and placing several on the head; Bashri et al. noted 
that the accuracy of microwave systems are dependent on 
the number of antennas.21 However, in exchange for in-
creased accuracy in spatial resolution comes the trade-off 
of increased device size and complexity. In addition, Alqa-
dami et al. reported that a maximum of 32 antennas can 
be placed to maximize the accuracy of microwave-based 
stroke detection devices.20 Microwave-based sensors hold 
significant future promise in rapid stroke detection if these 
limitations can be overcome.
Stroke Diagnosis Using EEG
Four studies successfully described EEG for stroke de-
tection. The first study was published by Michelson et al. 
in 2015 and demonstrated acute stroke diagnosis (ische-
mic and hemorrhagic) with high sensitivity (91.7%) and 
moderate specificity (50.4%).23 Further experimentation 
by Gottlibe et al., Shreve et al., and Wilkinson et al. con-
firmed the efficacy of EEG for ischemic stroke diagnosis 
using the changes in the revised brain symmetry index, 
alpha/delta frequency band ratios, and mixed delta/alpha 
ratio plus pairwise-derived brain symmetry index values, 
respectively.10,13,24 These studies suggested that EEG may 
accurately predict acute stroke within 3 minutes. In ad-
dition, EEG may be able to differentiate between hem-
orrhagic and ischemic stroke subtypes, since it has been 
shown to have an overall sensitivity of 91.7% for predict-
ing any stroke, sensitivity of 90.3% for ischemic stroke, 
and sensitivity of 94.1% for hemorrhagic stroke. However, 
the main limitation of EEG detection is the massive setup 
FIG. 2. Schematic demonstrating the use of each novel stroke technology. Made with a valid license in ©BioRender - biorender.
com.
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time normally associated with placing numerous leads on 
the head. Furthermore, if MRI is indicated, all magnetic 
leads must be taken off of the patient, which requires ad-
ditional time. Additional limitations include poor spatial 
resolution and that small infarcts or hemorrhages may not 
be detected using this method.
Stroke Diagnosis Using Ultrasonography
Ultrasound diagnosis of stroke is a nonionizing tech-
nique that is currently being investigated by several 
groups.25–27 The primary limitation of this technique is 
the need for ultrasound transducer materials to minimize 
signal attenuation. Even with appropriate transduction 
materials, the density of the skull contributes to signifi-
cant signal attenuation, and the temporal bone window is 
frequently used for intracranial ultrasound applications.26 
Even when implementing these findings, heavy computa-
tion is critical in accurately utilizing ultrasound for stroke 
diagnosis. Thorpe et al. demonstrated the calculation of a 
velocity curvature index from cerebral blood flow velocity 
using a transcranial Doppler probe.27 This method yielded 
a maximum area under the receiver operating characteris-
tic curve (AUC) of 0.94, which represents one of the high-
est metrics of device performance reported in the contem-
porary stroke diagnostic device literature.
Stroke Diagnosis Using NIRS
The FDA has approved the use of NIRS for detection 
of hemorrhagic stroke.9,15 Nonionizing NIRS to determine 
absorption of a 805-nm wavelength, which is sensitive to 
blood volume and not blood oxygen saturation.15 While 
this technology allows for rapid and compact scanning and 
has a cross-study sensitivity of 78%, specificity of 90%, 
positive predictive value of 77%, and negative predictive 
value of 90%, it has several major limitations.9 First, NIRS 
is unable to detect ischemic stroke and can only detect 
hemorrhagic stroke > 3.5 mL. Furthermore, NIRS can 
only detect hematomas within the most superficial 2.5 cm 
of the head. As such, this method is not helpful for detect-
ing deeper intracerebral hemorrhage (ICH) (such as some 
basal ganglia ICHs) and cannot yet distinguish between 
stroke subtypes to facilitate treatment. Additionally, the 
NIRS device is only probed at 8 unique points on the head 
and is not indicated for continuous scanning.
Stroke Diagnosis Using Portable MRI
Aside from novel diagnostic technologies, significant 
advances have taken place with regard to portable MRI 
scanners. Both Sheth et al. and Cooley et al. described 
these portable advancements, which boast many of the 
benefits of traditional MRI, including accurate neuroimag-
ing and millimeter resolution.28,29 However, portable MRI 
scanners have several limitations compared with the other 
stroke diagnostic devices, including much larger sizes, in-
creased power requirements, and increased device costs, 
limiting widespread availability.
Stroke Diagnosis Using VIPS
Another nonionizing stroke diagnostic technique is 
VIPS, which uses bioimpedance asymmetry scores to 
predict large-vessel occlusions.8 While the VIPS device is 
portable, noninvasive, and easy to use and has a sensitivity 
of 93% and specificity of 92% for large-vessel stroke, it has 
not yet been shown to work effectively for differentiation 
of ischemic and hemorrhagic stroke. In addition, VIPS de-
vices are extremely sensitive to metal (e.g., metallic im-
plants, metal objects worn in the hair), and the presence of 
metal can significantly disrupt the signal.
Stroke Diagnosis Using ECD
ECD sensors represent a nonionizing stroke diagnostic 
TABLE 3. Overview of stroke diagnostic technology included in this systematic review




Potential to  
Differentiate IS vs HS
Potential to Differentiate 
Stroke From Stroke Mimics
Potential to Detect 
LVO Stroke
Microwave Measuring microwave scattering due to the dielectric 
contrast of different tissue types; usually used in a 
helmet-like device w/ antennas
Yes Unknown No
EEG Using brain electrical activity to detect acute stroke Yes Not determined (specificity 
of 50.4% to stroke mimic in 
Michelson et al.23)
Unknown 
Ultrasonography Using ultrasound tomography to provide a 3D image 
of brain to diagnose acute stroke
No Unknown Yes
NIRS Detects absorption of 805-nm wavelength, which is 
sensitive to blood vol 
No No No
Portable MRI Portable, low-field MRI to detect acute stroke Yes Yes Yes
VIPS Uses array of low-energy radio waves to detect bio-
impedance of different tissue type & fluid properties
Unknown Yes Yes
ECD Measures changes in electrical conductivity in the 
brain by creating microtesla magnetic fields
Yes Unknown Unknown
“Unknown” is used in instances in which the comparison had not been studied or had not been well reported on. “Not determined” is used in instances in which a com-
parison had been reported but did not have definitive results. 
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technology.12 These sensors are 11 cm in diameter and op-
erate by creating microtesla-level magnetic fields capable 
of detecting changes in electrical conductivity within the 
brain, with ischemia having reduced conductivity and 
hemorrhage having increased conductivity. Prior studies 
have demonstrated a scanning depth of 5 cm into the brain, 
with accurate (100% detection) image production of hem-
orrhagic stroke within 2.43 minutes.12 However, current 
limits of hemorrhage detection have been reported to be 
25 mL, and it has been shown to also be sensitive to the 
presence of metal objects.
Discussion
The present systematic review describes contempo-
rary and evolving stroke diagnostic technologies, their 
proposed benefits and limitations, and current accuracy 
in diagnosis. Following our comprehensive review of the 
literature, we identified 7 diagnostic avenues that are cur-
rently being investigated or preliminarily implemented for 
the assessment of stroke. The primary benefit of next-gen-
eration stroke technology centers around portability. All 
of the studies included in this study emphasized the need 
for portable stroke-sensing capabilities to facilitate triage 
and save time compared with CT or MRI. Furthermore, 
rapid prehospital diagnosis (compared with traditional im-
aging) was emphasized as a potential benefit in all studies. 
A wide variety of limitations was also discussed for each 
diagnostic method. Most notably, scanning depth into the 
brain and the detection of submillimeter lesions require 
further investigation. In addition, VIPS and ECD sensors 
were highly sensitive to the presence of metal, which may 
be present as a medical implant or within patient clothing.
Recent technological advances have allowed for the de-
velopment of technologies for stroke detection and have 
also allowed for the modification of preexisting diagnostic 
devices for stroke applications. Technologies such as ultra-
sonography and EEG are being retrofitted for stroke appli-
cations thanks to recent computational advancements, in-
cluding finite element modeling and machine learning.24,30 
One major benefit of the utilization of preexisting diag-
nostic tools for stroke diagnostics is the well-understood 
risks and benefits associated with the technology. Such a 
thorough understanding also greatly reduces the difficulty 
of obtaining FDA approval, allowing for a shortened time-
line to market. Notable medical devices that accurately 
predicted stroke in our review included EEG-based diag-
nosis with a maximum sensitivity of 91.7% for predicting a 
stroke,23 microwave-based diagnosis with an AUC of 0.88 
for differentiating ischemic stroke and ICH,11 ultrasound 
with an AUC of 0.92,27 VIPS with an AUC of 0.93,8 and 
portable MRI with a diagnostic accuracy similar to that of 
traditional MRI.28,29
In addition, current technologies require further inno-
vation to accurately classify stroke subtypes while achiev-
ing acceptable scanning depths and volume sensitivity. 
As previously mentioned, FDA-approved NIRS methods 
are currently indicated only for suspected hemorrhagic 
stroke and cannot distinguish ischemic and hemorrhagic 
stroke subtypes.9,15 Furthermore, the moderate sensitiv-
ity of NIRS, volume limits, and detection range prevent 
it from being useful in cases of suspected deep or small 
ICHs.9,15 Similarly, microwave-based methods and EEG 
have also been described to have a limited ability for de-
tection of small hematomas, which prevents their use for 
high-accuracy stroke subtyping and for the guidance of 
thrombolytic administration.10,11, 13, 14,24 The technology that 
shows the greatest potential promise for the detection and 
classification of stroke subtypes is currently portable MRI, 
which essentially operates as a miniaturized compact ver-
sion of traditional MRI. However, these devices are much 
more expensive and much larger than comparable next-
generation stroke diagnostic technologies.28,29 Further re-
search on VIPS and ECD methods for stroke detection are 
necessary to fully understand their capabilities in ischemic 
and hemorrhagic stroke detection and classification.8
With the hope of further improving the detection of 
stroke, biomarker approaches are also being investigated 
but remain outside of the scope of this review. One of the 
best biomarker diagnostic performances described in the 
literature was achieved when using apolipoprotein A1-
unique peptide as a biomarker for acute ischemic stroke, 
with an AUC of 0.975, a sensitivity of 90.63%, and a speci-
ficity of 97.14%.31 Similarly, Tao et al. conducted a study 
with the second largest AUC of 0.879, which was achieved 
by combining lipoprotein-associated phospholipase A2, 
serum amyloid A, and fibrinogen as diagnostic biomark-
ers for acute cerebral infarction.32 However, among all 
of the blood-based biomarker diagnostic tests, one major 
problem remains: access to a laboratory for the analysis of 
blood components. This is a huge limitation, and labora-
tory processing times may take several additional hours 
depending on the assay required for diagnosis (e.g., en-
zyme-linked immunosorbent assay).
Limitations
There are several limitations to this study. First, many 
of the technologies described in this article are explor-
atory, and additional multicenter randomized controlled 
studies are necessary to fully confirm the efficacy of these 
stroke diagnostic methodologies. Second, significant het-
erogeneity existed within each novel diagnostic subgroup 
discussed in our review. This is likely due to the fact that 
optimal protocols have not yet been established because of 
the experimental nature of current investigations. Third, 
several of the devices discussed herein were specific for 
either ischemic or hemorrhagic stroke, and significant in-
novation is still required to differentiate the two subtypes.
Conclusions
As technology and computational resources have ad-
vanced, several next-generation medical devices have 
emerged that show promise in facilitating stroke diagnosis. 
These improvements include reduced diagnostic times, in-
creased device compactness allowing for portable diagno-
sis, and reduced device costs. As additional data continue 
to emerge regarding these novel methods, it is imperative 
to reexamine the current stroke diagnostic paradigm and 
updated guidelines for diagnosis and management appro-
priately. Overall, additional studies are necessary to thor-
oughly investigate the benefits and limitations of emerging 
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stroke diagnostic technologies with the hope of improving 
stroke management and reducing rates of mortality and 
morbidity associated with patient transport or imaging 
availability.
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